 |
|
|
| |
The Effect of Using Lower Limit of Quantitation (LLQ) vs Lower Limit of Detection (LLD) for the Definition of Undetectable HCV RNA: Data from the RESPOND-2 and SPRINT-2 trials
|
| |
| |
Reported by JulesLevin
AASLD Nov 5-8 2011 SF
E. Lawitz1, F. Poordad2, J-P. Bronowicki3, P. Marcellin4, S.V. Feinman5, P. Kwo6, D. Guyader7, M. Davis8, S. Harrison9, L. Pedicone10, R. Jiang10, M. Burroughs10, C. Brass10, J. Albrecht10, S. Zeuzem11
1Alamo Medical Research, San Antonio, TX, USA, 2Cedars-Sinai Medical Center, Los Angeles, CA, 3Universite Henri Poincare-Nancy 1, Vandoeuvre-les-Nancy, France, 4University Paris 7-Hôpital Beaujon, Clichy, France, 5Mount Sinai Hospital, 6Indiana University School of Medicine, 7C.H.R.U. de Rennes, Hopital de Pontchaillou, 8South Florida Center of Gastroenterology, Wellington, FL, 9Brooke Army Medical Center, Fort Sam Houston, TX, 10Merck, Whitehouse Station, NJ, 11J.W. Goethe University Hospital, Frankfurt, Germany.
|
| |
|
|
|
|
|
